New Mexico Administrative Code
Title 7 - HEALTH
Chapter 32 - ALCOHOL AND DRUG ABUSE
Part 8 - OPIOID TREATMENT PROGRAMS
Section 7.32.8.22 - DRUG SCREENING

Universal Citation: 7 NM Admin Code 7.32.8.22

Current through Register Vol. 35, No. 6, March 26, 2024

The program sponsor shall ensure that:

A. staff members have knowledge of the benefits and limitations of laboratory drug detection tests and other toxicological testing procedures;

B. a patient in comprehensive maintenance treatment receives at least eight random laboratory drug detection tests per year; short-term opioid treatment withdrawal procedure patients receive at least one initial drug abuse test; long-term opioid treatment withdrawal procedure patients receive an initial and monthly random tests; and other toxicological tests are performed according to written orders from the program medical director or medical practitioner designee;

C. laboratory drug detection tests and other toxicological testing specimens are collected in a manner that minimizes falsification;

D. laboratory drug detection tests for:

(1) opioids;

(2) methadone;

(3) amphetamines;

(4) cocaine;

(5) barbiturates;

(6) benzodiazepines; and

(7) other substances as may be appropriate, based upon patient history and prevailing patterns of drug availability and use in the local area;

E. the results of a patient's laboratory drug detection tests or other toxicological test and any action taken relating to the results are documented in the patient record.

Disclaimer: These regulations may not be the most recent version. New Mexico may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.